Terms: = Breast cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Prognosis
14 results:
1. Mutant npm1 maintains RASGRP3 protein stability via interaction with MID1 to promote acute myeloid leukemia cell proliferation and autophagy.
Wang Y; Pan C; Zhang X; Zhao A; Dong Y
J Leukoc Biol; 2023 May; 113(5):504-517. PubMed ID: 36826998
[TBL] [Abstract] [Full Text] [Related]
2. Clinical outcomes associated with npm1 mutations in patients with relapsed or refractory AML.
Issa GC; Bidikian A; Venugopal S; Konopleva M; DiNardo CD; Kadia TM; Borthakur G; Jabbour E; Pemmaraju N; Yilmaz M; Short NJ; Maiti A; Sasaki K; Masarova L; Pierce S; Takahashi K; Tang G; Loghavi S; Patel K; Andreeff M; Bhalla K; Garcia-Manero G; Ravandi F; Kantarjian H; Daver N
Blood Adv; 2023 Mar; 7(6):933-942. PubMed ID: 36322818
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications.
Nilsson C; Linde F; Hulegårdh E; Garelius H; Lazarevic V; Antunovic P; Cammenga J; Deneberg S; Eriksson A; Jädersten M; Björkvall CK; Möllgård L; Wennström L; Ölander E; Höglund M; Juliusson G; Lehmann S
Haematologica; 2023 Apr; 108(4):1015-1025. PubMed ID: 36005563
[TBL] [Abstract] [Full Text] [Related]
4. Myeloid Sarcoma of the breast as Blast Phase of JAK2-Mutated (Val617Phe Exon 14p) Essential Thrombocythemia: A Case Report and a Systematic Literature Review.
Pace M; Guadagno E; Russo D; Gencarelli A; Carlea A; Di Spiezio A; Bertuzzi C; Mascolo M; Grimaldi F; Insabato L
Pathobiology; 2023; 90(2):123-130. PubMed ID: 35850113
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with breast cancer.
Al-Shamsi HO; Abu-Gheida I; Abdulsamad AS; AlAwadhi A; Alrawi S; Musallam KM; Arun B; Ibrahim NK
Oncologist; 2021 Nov; 26(11):e2086-e2089. PubMed ID: 34327780
[TBL] [Abstract] [Full Text] [Related]
6. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
[TBL] [Abstract] [Full Text] [Related]
7. Proteomics evaluation of MDA-MB-231 breast cancer cells in response to RNAi-induced silencing of hPTTG.
Khazaei G; Shamsabadi FT; Yamchi A; Golalipour M; Jhingan GD; Shahbazi M
Life Sci; 2019 Dec; 239():116873. PubMed ID: 31521689
[TBL] [Abstract] [Full Text] [Related]
8. APE1 and npm1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC.
Malfatti MC; Gerratana L; Dalla E; Isola M; Damante G; Di Loreto C; Puglisi F; Tell G
J Exp Clin Cancer Res; 2019 Jul; 38(1):309. PubMed ID: 31307523
[TBL] [Abstract] [Full Text] [Related]
9. Expression of nucleophosmin/npm1 correlates with migration and invasiveness of colon cancer cells.
Liu Y; Zhang F; Zhang XF; Qi LS; Yang L; Guo H; Zhang N
J Biomed Sci; 2012 May; 19(1):53. PubMed ID: 22631075
[TBL] [Abstract] [Full Text] [Related]
10. An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer.
Karhemo PR; Rivinoja A; Lundin J; Hyvönen M; Chernenko A; Lammi J; Sihto H; Lundin M; Heikkilä P; Joensuu H; Bono P; Laakkonen P
Am J Pathol; 2011 Aug; 179(2):1004-14. PubMed ID: 21689627
[TBL] [Abstract] [Full Text] [Related]
11. prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant breast and Bowel Project protocols of node-negative breast cancer.
Anderson SJ; Wapnir I; Dignam JJ; Fisher B; Mamounas EP; Jeong JH; Geyer CE; Wickerham DL; Costantino JP; Wolmark N
J Clin Oncol; 2009 May; 27(15):2466-73. PubMed ID: 19349544
[TBL] [Abstract] [Full Text] [Related]
12. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Mrózek K; Döhner H; Bloomfield CD
Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
[TBL] [Abstract] [Full Text] [Related]
13. A population survival model for breast cancer.
Stracci F; La Rosa F; Falsettini E; Ricci E; Aristei C; Bellezza G; Bolis GB; Fenocchio D; Gori S; Rulli A; Mastrandrea V
Breast; 2005 Apr; 14(2):94-102. PubMed ID: 15767178
[TBL] [Abstract] [Full Text] [Related]
14. Combinatorial effects of monoclonal anti-p120 antibody (MAbp120), liposomes and hyperthermia on MCF-7 and LOX tumor cell lines.
Perlaky L; Busch RK; Busch H
Oncol Res; 1996; 8(9):363-9. PubMed ID: 8979270
[TBL] [Abstract] [Full Text] [Related]
